Insights into Imaging (Mar 2024)

PI-RADS v2.1 evaluation of prostate “nodule in nodule” variants: clinical, imaging, and pathological features

  • MingHua Sun,
  • Li Xu,
  • XiaoYan Zhang,
  • LiYu Cao,
  • WenBao Chen,
  • Kai Liu,
  • Hao Wu,
  • DongDong Xie

DOI
https://doi.org/10.1186/s13244-024-01651-6
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Objectives To analyze the correlation among the imaging features of prostate “nodule in nodule,” clinical prostate indices, and pathology results. Methods We retrospectively analyzed the prostate images from 47 male patients who underwent MRI scans and pathological biopsy from January 2022 to July 2023. Two radiologists (R1/R2) evaluated the morphology and signal intensity of the “nodule in nodule” in a double-blind manner and calculated the PI-RADS v2.1 score, which was compared with clinical prostate indices and pathological results. Results 34.04% (16/47) of patients were pathologically diagnosed with clinically significant prostate cancer (csPCa). Total prostate-specific antigen (tPSA), free/t PSA, PSA density (PSAD), and prostate gland volume (PGV) were significantly different between csPCa patients and benign prostatic hyperplasia (BPH) patients with prostate “nodule in nodule”. R1/R2 detected 17/17 prostate “nodule in nodule” pathologically confirmed as csPCa on MRI; 10.60% (16/151) (R1) and 11.11% (17/153) (R2) had diffusion-weighted imaging (DWI) PI-RADS v2.1 score of 4, and 0.66% (1/151) (R1) had a score of 3. The percentages of encapsulated, circumscribed, and atypical nodules and obscured margins were 0.00% (0/151), 0.00% (0/151), 5.96% (9/151), and 5.30% (8/151), respectively, for R1, and 0.00% (0/153), 0.00% (0/153), 5.88% (9/153), and 4.58% (7/153) for R2. Conclusion When the inner nodules of “nodule in nodule” lesions in PI-RADS v2.1 category 1 in the TZ show incomplete capsulation or obscured margins, they are considered atypical nodules and might be upgraded to PI-RADS v2.1 category 3 if they exhibit marked diffusion restriction. However, further validation is needed. Critical relevance statement This study first analyzed the relationship between clinical and pathological findings and the size, margin, and multimodal MRI manifestations of the prostate “nodule in nodule.” These findings could improve the diagnostic accuracy of PI-RADS v2.1 for prostate lesions. Key points • The margin of the prostate inner nodules affects the PI-RADS v2.1 score. • The morphology of prostate “nodule in nodule” is related to their pathology. • The PI-RADS v2.1 principle requires consideration of prostate “nodule in nodule” variants. Graphical Abstract

Keywords